Merck Receives FDA Breakthrough Therapy Designation for Sac-TMT
| IMANX Fund | USD 16.89 0.17 1.02% |
Slightly above 50% of Iman Fund's investors are presently thinking to get in. The analysis of overall sentiment of trading Iman Fund Class mutual fund suggests that some investors are interested at this time. Iman Fund's investing sentiment can be driven by a variety of factors including economic data, Iman Fund's earnings reports, geopolitical events, and overall market trends.
Iman |
Merck announced that the U.S. FDA has granted Breakthrough Therapy Designation to its investigational antibody-drug conjugate , sacituzumab tirumotec
Read at gurufocus.com
 |
Iman Fund Fundamental Analysis
We analyze Iman Fund's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Iman Fund using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Iman Fund based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Iman Fund is currently under evaluation in price to sales among similar funds. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Iman Fund Class Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iman Fund mutual fund to make a market-neutral strategy. Peer analysis of Iman Fund could also be used in its relative valuation, which is a method of valuing Iman Fund by comparing valuation metrics with similar companies.
Peers
Iman Fund Related Equities
| AMAGX | Amana Growth | 0.99 | ||||
| ADJEX | Azzad Ethical | 0.95 | ||||
| AMANX | Amana Income | 0.04 | ||||
| WISEX | Azzad Wise | 0.09 | ||||
| AMDWX | Amana Developing | 0.80 |
Other Information on Investing in Iman Mutual Fund
Iman Fund financial ratios help investors to determine whether Iman Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Iman with respect to the benefits of owning Iman Fund security.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |